We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$964M
AUM Growth
-$140M
Cap. Flow
-$172M
Cap. Flow %
-17.82%
Top 10 Hldgs %
4.43%
Holding
1,380
New
507
Increased
200
Reduced
258
Closed
407

Top Sells

Rank Stock Value
1
AI icon
C3.ai
AI
+$8.92M
2
CSX icon
CSX Corp
CSX
+$8.9M
3
QCOM icon
Qualcomm
QCOM
+$8.55M
4
META icon
Meta Platforms (Facebook)
META
+$8.54M
5
BF.B icon
Brown-Forman Class B
BF.B
+$8.46M

Sector Composition

Rank Sector Weight
1 Technology 22.9%
2 Industrials 19.62%
3 Consumer Discretionary 17.88%
4 Financials 6.99%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEI icon
951
American Public Education
APEI
$890M
$71.4K 0.01%
15,072
-54,176
-78% -$295K
LONA
952
LeonaBio Inc
LONA
$66.3M
$68.2K 0.01%
2,313
-2,091
-47% -$59.6K
LAB icon
953
Standard BioTools
LAB
$340M
$63.6K 0.01%
+32,954
New +$65K
KRON
954
DELISTED
Kronos Bio
KRON
$62.9K 0.01%
36,552
TTI icon
955
TETRA Technologies
TTI
$1.14B
$58.3K 0.01%
17,253
-70,590
-80% -$204K
RLMD icon
956
Relmada Therapeutics
RLMD
$557M
$56.4K 0.01%
22,941
-16,219
-41% -$44.8K
GAN
957
DELISTED
GAN Ltd
GAN
$53.7K 0.01%
32,764
BCOV
958
DELISTED
Brightcove, Inc.
BCOV
$50.5K 0.01%
+12,594
New +$50.9K
BCLI
959
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$50.3K 0.01%
+1,626
New +$67.4K
SKIL icon
960
Skillsoft
SKIL
$63.7M
$49.5K 0.01%
1,996
-2,271
-53% -$66.3K
KNTE
961
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$46.8K ﹤0.01%
+15,435
New +$59.5K
FREE
962
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$45K ﹤0.01%
+11,203
New +$31.2K
CMLS
963
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$44.7K ﹤0.01%
10,899
-22,527
-67% -$75.7K
KRMD icon
964
KORU Medical Systems
KRMD
$189M
$43.7K ﹤0.01%
+12,664
New +$49.7K
PSTX
965
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$41.2K ﹤0.01%
+23,427
New +$59.8K
NUVB icon
966
Nuvation Bio
NUVB
$2.2B
$38.4K ﹤0.01%
21,331
-31,787
-60% -$54K
CELL
967
DELISTED
PhenomeX Inc. Common Stock
CELL
$33.7K ﹤0.01%
68,759
SMSI icon
968
Smith Micro Software
SMSI
$14.5M
$32.7K ﹤0.01%
735
ADVM
969
DELISTED
Adverum Biotechnologies
ADVM
$30.9K ﹤0.01%
1,943
-3,313
-63% -$34.8K
SLDP icon
970
Solid Power
SLDP
$463M
$28.5K ﹤0.01%
+11,211
New +$25.9K
UP icon
971
Wheels Up
UP
$208M
$28.4K ﹤0.01%
+1,216
New +$85.9K
ENZ
972
DELISTED
Enzo Biochem, Inc.
ENZ
$21.2K ﹤0.01%
+11,534
New +$26.7K
TIL icon
973
Instil Bio
TIL
$48.3M
$8.6K ﹤0.01%
780
ABCB icon
974
Ameris Bancorp
ABCB
$5.85B
-13,567
Closed -$496K
ABNB icon
975
Airbnb
ABNB
$89.9B
-24,100
Closed -$3M

Similar funds

Occudo Quantitative Strategies's Q2 2023 Portfolio in Review

As of Q2 2023, Occudo Quantitative Strategies held 1,380 positions worth $964M, down 13% from $1.1B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

Occudo Quantitative Strategies withdrew a net $172M in Q2 2023, closing 407 positions and reducing 258 holdings. Its most notable exit was C3.ai, an estimated $8.92M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Occudo Quantitative Strategies opened a new position in Academy Sports + Outdoors worth $4.25M.

  • Occudo Quantitative Strategies's largest Q2 2023 buy was Academy Sports + Outdoors: 78,545 shares worth $4.25M.
  • Occudo Quantitative Strategies added most to Erie Indemnity in Q2 2023, an estimated $4.12M increase.
  • Occudo Quantitative Strategies's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $8.54M.
  • Occudo Quantitative Strategies fully exited C3.ai in Q2 2023, selling an estimated $8.92M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.4% of its $964M portfolio in Q2 2023.
  • Occudo Quantitative Strategies opened 507 new positions and closed 407 in Q2 2023.
  • Occudo Quantitative Strategies's portfolio value fell 13% quarter-over-quarter to $964M.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.